The prevalence of patients with peripheral artery disease (PAD) is high and increasing worldwide with morbidities that include the need for limb revascularization or amputation.
1-6 Previous studies regarding the rate of limb outcomes have been limited to registry studies
7,8 and select patient subgroups, including those with critical limb ischemia (CLI),
9-14 prior amputation, or revascularization.
15-17 Moreover, the potential role of noninvasive evaluation by lower extremity ankle-brachial indices (ABIs) for risk assessment and the rates for amputation or revascularization in nonselected patients with PAD from the community have not been established to date.